NYSE:LCI

Lannett - LCI Stock Forecast, Price & News

$0.49

+0.01 (+2.26%)

(As of 10/7/2022 10:27 AM ET)

Add

Compare

Today's Range: $0.49
▼
$0.49
50-Day Range: $0.45
▼
$0.63
52-Week Range: $0.43
▼
$2.78

Volume: 314 shs
Average Volume: 176,423 shs
Market Capitalization: $21.18 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Lannett MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
11.90% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.45
Based on 2 Articles This Week
Insider Trading: Acquiring Shares
$15,268 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($1.68) to ($1.33) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.08 out of 5 stars

Medical Sector

1059th out of 1,075 stocks

Pharmaceutical Preparations Industry

530th out of 537 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Lannett.

0.0

Short Interest

Percentage of Shares Shorted
11.90% of the float of Lannett has been sold short.
Short Interest Ratio / Days to Cover
Lannett has a short interest ratio ("days to cover") of 22.4, which indicates bearish sentiment.
Change versus previous month

0.0

Dividend Strength

Dividend Yield
Lannett does not currently pay a dividend.
Dividend Growth
Lannett does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LCI.

1.9

News and Social Media Coverage

News Sentiment
Lannett has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Lannett this week, compared to 1 article on an average week.
Search Interest
Only 1 people have searched for LCI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
Only 1 people have added Lannett to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Lannett insiders have bought more of their company's stock than they have sold. Specifically, they have bought $15,268.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
14.67% of the stock of Lannett is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
44.11% of the stock of Lannett is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Lannett are expected to grow in the coming year, from ($1.68) to ($1.33) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Lannett is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Lannett is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About Lannett (NYSE:LCI) Stock

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's product portfolio includes Amphetamine IR tablets, Amphetamine ER capsules, Dicyclomine tablets, Fluphenazine tablets, Levothyroxine capsules, Methylphenidate CD capsules, Methylphenidate ER, Posaconazole DR tablets, Probenecid tablets, and Verapamil SR tablets, as well as Numbrino nasal solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, Sinotherapeutics, Respirent Pharmaceuticals Co., Ltd., HEC Pharm Group, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

Receive LCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

LCI Stock News Headlines

October 5, 2022 | finance.yahoo.com

Lannett Company, Inc. (LCI)

October 1, 2022 | americanbankingnews.com

Lannett (NYSE:LCI) Now Covered by StockNews.com

September 26, 2022 | forbes.com

Probability Of Default Is Rising For High Yield Bonds And Leveraged Loans - Forbes

September 19, 2022 | bloomberg.com

Adderall Shortages in US Spread to Two More Drug Suppliers - Bloomberg

September 19, 2022 | benzinga.com

Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket - Amprius Technologies (NYSE:AMPX), Golden Minerals (AMEX:AUMN) - Benzinga

September 16, 2022 | benzinga.com

12 Health Care Stocks Moving In Friday's Intraday Session - Anixa Biosciences (NASDAQ:ANIX), Apexigen (NASDAQ:APGN) - Benzinga

September 11, 2022 | thestreet.com

Lannett (LCI) Is Today's Water-Logged And Getting Wetter Stock

September 2, 2022 | finance.yahoo.com

LANNETT ANNOUNCES SUBJECT DOSING COMPLETE FOR PIVOTAL CLINICAL TRIAL OF BIOSIMILAR INSULIN GLARGINE - Yahoo Finance

August 31, 2022 | finance.yahoo.com

LANNETT ANNOUNCES SUBJECT DOSING COMPLETE FOR PIVOTAL CLINICAL TRIAL OF BIOSIMILAR INSULIN GLARGINE

August 27, 2022 | finance.yahoo.com

News Flash: 2 Analysts Think Lannett Company, Inc. (NYSE:LCI) Earnings Are Under Threat - Yahoo Finance

August 27, 2022 | finance.yahoo.com

News Flash: 2 Analysts Think Lannett Company, Inc. (NYSE:LCI) Earnings Are Under Threat

August 25, 2022 | seekingalpha.com

Lannett Company, Inc. (LCI) CEO Timothy Crew on Q4 2022 Results - Earnings Call Transcript

August 25, 2022 | benzinga.com

Looking Into Lannett's Return On Capital Employed

August 25, 2022 | finance.yahoo.com

Lannett Clocks 30% Top-Line Decline In Q4, Forecasts Lower FY23 Sales

August 25, 2022 | finance.yahoo.com

Edited Transcript of LCI.N earnings conference call or presentation 24-Aug-22 8:30pm GMT

August 25, 2022 | investing.com

Lannett Tops Q2 EPS by 2c By Investing.com - Investing.com

August 24, 2022 | uk.investing.com

Lannett Tops Q2 EPS by 2c By Investing.com - Investing.com UK

August 24, 2022 | finance.yahoo.com

LANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS - Yahoo Finance

August 24, 2022 | finance.yahoo.com

LANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS

August 23, 2022 | benzinga.com

Earnings Preview: Lannett - Benzinga

August 19, 2022 | benzinga.com

LANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNES - Benzinga

August 19, 2022 | finance.yahoo.com

LANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, AUGUST 24

August 15, 2022 | finance.yahoo.com

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2023 ended June 30, 2022, and Provides Conference Call Information - Yahoo Finance

August 10, 2022 | globenewswire.com

Societal CDMO Reports Second Quarter 2022 Financial Results - GlobeNewswire

August 2, 2022 | benzinga.com

The Global Malabsorption Syndrome Market is expected to grow by $ 1.55 bn during 2022-2026, accelerating - Benzinga

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive LCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

LCI Company Calendar

Last Earnings: 8/24/2022
Today: 10/07/2022
Next Earnings (Estimated): 11/02/2022
Fiscal Year End: 6/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceutical preparations
Sub-Industry: Pharmaceuticals
Sector: Medical
Current Symbol: NYSE:LCI
CUSIP: 51601210
CIK: 57725
Web: www.lannett.com
Phone: (215) 333-9000
Fax: 215-333-9004
Employees: 810
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($5.73)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-231,620,000.00
Net Margins: -68.01%
Pretax Margin: -68.68%
Return on Equity: N/A
Return on Assets: -10.42%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.76
Quick Ratio: 1.86

Sales & Book Value

Annual Sales: $340.58 million
Price / Sales: 0.06
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($5.83) per share
Price / Book: -0.08

Miscellaneous

Outstanding Shares: 42,960,000
Free Float: 36,658,000
Market Cap: $21.18 million
Optionable: Optionable
Beta: 0.97

Key Executives

Mr. Timothy C. Crew (Age 61)
CEO & Director
Comp: $999.47k

Mr. John Kozlowski (Age 50)
VP of Fin., CFO & Principal Accounting Officer
Comp: $537.48k

Mr. John M. Abt (Age 57)
VP and Chief Quality, Information Technology & Operations Officer
Comp: $491.53k

Mr. Samuel H. Israel (Age 60)
Gen. Counsel & Chief Legal Officer
Comp: $526.15k

Ms. Maureen M. Cavanaugh (Age 62)
Sr. VP & Chief Commercial Operations Officer
Comp: $551.27k

Ms. Kristie Stephens
Chief Compliance Officer & VP of Regulatory Affairs

Mr. Grant Brock
VP of Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

LCI Stock - Frequently Asked Questions

How have LCI shares performed in 2022?: Lannett's stock was trading at $1.62 at the beginning of the year. Since then, LCI stock has decreased by 70.2% and is now trading at $0.4821.
View the best growth stocks for 2022 here.
Are investors shorting Lannett?: Lannett saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 3,890,000 shares, a decline of 7.6% from the August 15th total of 4,210,000 shares. Based on an average trading volume of 223,900 shares, the short-interest ratio is currently 17.4 days. Currently, 11.9% of the shares of the stock are short sold.
View Lannett's Short Interest.
When is Lannett's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our LCI earnings forecast.
How were Lannett's earnings last quarter?: Lannett Company, Inc. (NYSE:LCI) announced its quarterly earnings results on Wednesday, August, 24th. The company reported ($0.44) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.46) by $0.02. The business had revenue of $74.19 million for the quarter, compared to analysts' expectations of $74.65 million. During the same quarter last year, the company posted ($0.19) EPS.
What guidance has Lannett issued on next quarter's earnings?: Lannett issued an update on its FY 2023 earnings guidance on Tuesday, September, 20th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $275.00 million-$300.00 million, compared to the consensus revenue estimate of $332.05 million.
What is Timothy Crew's approval rating as Lannett's CEO?: 9 employees have rated Lannett Chief Executive Officer Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among the company's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Lannett own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).
What is Lannett's stock symbol?: Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."
How do I buy shares of Lannett?: Shares of LCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Lannett's stock price today?: One share of LCI stock can currently be purchased for approximately $0.48.
How much money does Lannett make?: Lannett (NYSE:LCI) has a market capitalization of $20.71 million and generates $340.58 million in revenue each year. The company earns $-231,620,000.00 in net income (profit) each year or ($5.73) on an earnings per share basis.
How many employees does Lannett have?: The company employs 810 workers across the globe.
How can I contact Lannett?: Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The official website for the company is www.lannett.com. The company can be reached via phone at (215) 333-9000 or via fax at 215-333-9004.

This page (NYSE:LCI) was last updated on 10/7/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Lannett - LCI Stock Forecast, Price & News

Lannett MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows